PMV Pharmaceuticals(PMVP)_个股概要_股票价格_最新资讯_行情走势_历史数据 - 老虎社区

应交易所要求，美/港股行情延时15分钟展示，下载APP即可免费查看实时行情。

关闭

PMVP PMV Pharmaceuticals

盘后交易 10-30 19:46:28 EDT

1.31

-0.04

-2.96%

盘后1.31

+0.000.00%

19:30 EDT

最高1.33	最低1.21	成交量121.29万
今开1.33	昨收1.35	日振幅8.96%
总市值9,892万	流通市值8,010万	总股本7,551万
成交额153.57万	换手率1.98%	流通股本6,114万
市净率--	ROE--	每股收益0.00
52周最高--	52周最低--	市盈率--
股息--	股息收益率--	ROA--

数据加载中...

北京优虎网络科技有限公司

{"stockData":{"symbol":"PMVP","market":"US","secType":"STK","nameCN":"PMV Pharmaceuticals","latestPrice":1.31,"timestamp":1793390400000,"preClose":1.35,"halted":0,"volume":1212925,"hourTrading":{"tag":"盘后","latestPrice":1.31,"preClose":1.31,"latestTime":"19:30 EDT","volume":84,"amount":109.2299964,"timestamp":1793403002105,"change":0,"changeRate":0,"amplitude":0.007634},"delay":0,"changeRate":-0.029629629629629655,"floatShares":61143700,"shares":75513100,"eps":-1.413098,"marketStatus":"盘后交易","change":-0.04,"latestTime":"10-30 19:46:28 EDT","open":1.33,"high":1.331,"low":1.21,"amount":1535717.4553524998,"amplitude":0.08963,"askPrice":1.32,"askSize":100,"bidPrice":1.24,"bidSize":100,"shortable":0,"etf":0,"ttmEps":-1.413098,"tradingStatus":3,"nextMarketStatus":{"tag":"收盘","tradingStatus":0,"beginTime":1793404800000},"marketStatusCode":4,"adr":0,"listingDate":1601006400000,"exchange":"NASDAQ","adjPreClose":1.35,"preHourTrading":{"tag":"盘前","latestPrice":1.3,"preClose":1.35,"latestTime":"07:08 EDT","volume":18250,"amount":23725,"timestamp":1793358532674,"change":-0.05,"changeRate":-0.037037,"amplitude":0},"postHourTrading":{"tag":"盘后","latestPrice":1.31,"preClose":1.31,"latestTime":"19:30 EDT","volume":84,"amount":109.2299964,"timestamp":1793403002105,"change":0,"changeRate":0,"amplitude":0.007634},"volumeRatio":3.403737,"impliedVol":1.8124,"impliedVolPercentile":0.996},"requestUrl":"/m/hq/s/PMVP/tweets","defaultTab":"tweets","newsList":[{"id":"1139755386","title":"PMV Pharmaceuticals公布Rezatapopt单药疗法治疗卵巢癌的最新积极中期数据","url":"https://stock-news.laohu8.com/highlight/detail?id=1139755386","media":"美股速递","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/1139755386?lang=zh_cn&edition=full","pubTime":"2026-09-01 04:02","pubTimestamp":1788206528,"startTime":"0","endTime":"0","summary":"PMV Pharmaceuticals今日宣布，其Rezatapopt单药疗法在Pynnacle二期关键试验中，针对卵巢癌患者的最新中期数据展现出令人鼓舞的疗效。\n这些数据进一步巩固了该药物作为潜在治疗方案的临床价值，为后续研发路径提供了有力支撑。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4139","PMVP"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1118343504","title":"PMV Pharmaceuticals第二季度每股亏损0.34美元","url":"https://stock-news.laohu8.com/highlight/detail?id=1118343504","media":"投资观察","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/1118343504?lang=zh_cn&edition=full","pubTime":"2026-08-14 20:18","pubTimestamp":1786709919,"startTime":"0","endTime":"0","summary":"PMV Pharmaceuticals公布了第二季度财报。数据显示，公司运营支出达到1888.1万美元，每股亏损为0.34美元。","market":"hk","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["PMVP","BK4139"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1154429326","title":"PMV Pharmaceuticals预计2027年第一季度提交TP53 Y220C突变卵巢癌药物Rezatapopt的新药申请","url":"https://stock-news.laohu8.com/highlight/detail?id=1154429326","media":"美股速递","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/1154429326?lang=zh_cn&edition=full","pubTime":"2026-04-22 20:02","pubTimestamp":1776859335,"startTime":"0","endTime":"0","summary":"生物制药公司PMV Pharmaceuticals宣布，其针对TP53 Y220C突变卵巢癌的候选药物Rezatapopt，预计将于2027年第一季度向监管机构提交新药申请。该时间表标志着公司在该精准疗法开发道路上的一个重要里程碑。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["PMVP","BK4139"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2518280244","title":"Pmv Pharmaceuticals, Inc.2024财年实现净利润-58.71百万美元，同比增加14.86%","url":"https://stock-news.laohu8.com/highlight/detail?id=2518280244","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2518280244?lang=zh_cn&edition=full","pubTime":"2025-03-09 00:01","pubTimestamp":1741449676,"startTime":"0","endTime":"0","summary":"3月9日，Pmv Pharmaceuticals, Inc.公布财报，公告显示公司2024财年净利润为-58.71百万美元，同比增加14.86%；其中营业收入为0.00美元，每股基本收益为-1.14美元。从资产负债表来看，Pmv Pharmaceuticals, Inc.总负债15.21百万美元，其中短期债务352000.00美元，资产负债比为0.13，流动比率为0.13。机构评级：截至2025年3月9日，当前有2家机构对Pmv Pharmaceuticals, Inc.目标价做出预测，其中目标均价为6.00美元，其中最低目标价为6.00美元，最高目标价为6.00美元。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250309000247abef9897&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250309000247abef9897&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["PMVP"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2517294157","title":"Pmv Pharmaceuticals, Inc.盘中异动 快速拉升5.43%报1.36美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2517294157","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2517294157?lang=zh_cn&edition=full","pubTime":"2025-03-06 00:17","pubTimestamp":1741191469,"startTime":"0","endTime":"0","summary":"北京时间2025年03月06日00时17分，Pmv Pharmaceuticals, Inc.股票出现波动，股价快速上涨5.43%。截至发稿，该股报1.36美元/股，成交量2.4529万股，换手率0.05%，振幅3.10%。Pmv Pharmaceuticals, Inc.股票所在的生物技术行业中，整体涨幅为1.22%。其相关个股中，Chimerix, Inc.、Nutriband Inc C/Wts 、Oculis Holding Ag C/Wts 06/03/2028 涨幅较大，Silexion Therapeutics Corp、Tc Biopharm  Plc、Bioxcel Therapeutics, Inc.较为活跃，换手率分别为895.98%、291.92%、278.42%，振幅较大的相关个股有Nkgen Biotech, Inc.、Klotho Neurosciences Inc C/Wts 21/06/2029 、Silexion Therapeutics Corp C/Wts Exp 15/08/2029 ，振幅分别为82.59%、54.27%、41.26%。Pmv Pharmaceuticals, Inc.公司简介：PMV Pharmaceuticals Inc是一家精密肿瘤学公司。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250306001749abe9d190&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250306001749abe9d190&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["PMVP","BK4139"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2516942665","title":"Pmv Pharmaceuticals, Inc.盘中异动 快速下挫5.11%","url":"https://stock-news.laohu8.com/highlight/detail?id=2516942665","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2516942665?lang=zh_cn&edition=full","pubTime":"2025-03-04 04:59","pubTimestamp":1741035598,"startTime":"0","endTime":"0","summary":"北京时间2025年03月04日04时59分，Pmv Pharmaceuticals, Inc.股票出现异动，股价急速下挫5.11%。Pmv Pharmaceuticals, Inc.股票所在的生物技术行业中，整体跌幅为0.18%。其相关个股中，Bioxcel Therapeutics, Inc.、Abpro Holdings Inc C/Wts 12/11/2029 、Cardio Diagnostics Holdings Inc C/Wts  To Pur Com涨幅较大，Bioxcel Therapeutics, Inc.、Allarity Therapeutics, Inc.、Entero Therapeutics Inc.较为活跃，换手率分别为4716.41%、220.71%、191.83%，振幅较大的相关个股有Bioxcel Therapeutics, Inc.、Radiopharm Theranostics Limited、Entero Therapeutics Inc.，振幅分别为206.20%、119.50%、70.53%。Pmv Pharmaceuticals, Inc.公司简介：PMV Pharmaceuticals Inc是一家精密肿瘤学公司。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250304045959989a651c&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250304045959989a651c&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","PMVP"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1182188421","title":"PMV制药2024财年GAAP每股收益$(1.14)未达$(1.08)预期","url":"https://stock-news.laohu8.com/highlight/detail?id=1182188421","media":"财报速递","labels":["express"],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/1182188421?lang=zh_cn&edition=full","pubTime":"2025-03-03 21:13","pubTimestamp":1741007594,"startTime":"0","endTime":"0","summary":"PMV制药 (NASDAQ: PMVP) 公布2024财年季度每股亏损$(1.14)，未达到分析师普遍预期的$(1.08)，差距为5.56%。以上内容来自Benzinga Earnings专栏，原文如下：PMV Pharma (NASDAQ:PMVP) reported quarterly losses of $(1.14) per share which missed the analyst consensus estimate of $(1.08) by 5.56 percent.","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":"PMV制药2024财年GAAP每股收益$(1.14)未达$(1.08)预期","news_tag":"express","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["PMVP"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2512484836","title":"Pmv Pharmaceuticals, Inc.盘中异动 早盘股价大涨5.84%","url":"https://stock-news.laohu8.com/highlight/detail?id=2512484836","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2512484836?lang=zh_cn&edition=full","pubTime":"2025-02-20 00:13","pubTimestamp":1739981602,"startTime":"0","endTime":"0","summary":"北京时间2025年02月20日00时13分，Pmv Pharmaceuticals, Inc.股票出现异动，股价快速拉升5.84%。截至发稿，该股报1.45美元/股，成交量33.7543万股，换手率0.65%，振幅5.11%。Pmv Pharmaceuticals, Inc.股票所在的生物技术行业中，整体涨幅为0.49%。其相关个股中，Osr Holdings, Inc.、Osr Holdings Inc C/Wts 02/09/2028 、Neurosense Therapeutics Ltd C/Wts 10/11/2026 涨幅较大，Aditxt, Inc.、Alzamend Neuro, Inc.、Osr Holdings, Inc.较为活跃，换手率分别为572.83%、243.17%、183.65%，振幅较大的相关个股有Osr Holdings Inc C/Wts 02/09/2028 、Osr Holdings, Inc.、Aditxt, Inc.，振幅分别为207.68%、159.49%、48.18%。Pmv Pharmaceuticals, Inc.公司简介：PMV Pharmaceuticals Inc是一家精密肿瘤学公司。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250220001322988b4186&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250220001322988b4186&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["PMVP","BK4139"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2511250805","title":"Pmv Pharmaceuticals, Inc.盘中异动 股价大涨5.15%","url":"https://stock-news.laohu8.com/highlight/detail?id=2511250805","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2511250805?lang=zh_cn&edition=full","pubTime":"2025-02-13 22:33","pubTimestamp":1739457235,"startTime":"0","endTime":"0","summary":"北京时间2025年02月13日22时33分，Pmv Pharmaceuticals, Inc.股票出现异动，股价急速上涨5.15%。Pmv Pharmaceuticals, Inc.股票所在的生物技术行业中，整体涨幅为0.17%。其相关个股中，Edesa Biotech, Inc.、Tc Biopharm  Plc C/Wts 10/02/2028 、Pliant Therapeutics, Inc.涨幅较大，Tc Biopharm  Plc、Edesa Biotech, Inc.、Genprex, Inc.较为活跃，换手率分别为988.32%、824.29%、93.91%，振幅较大的相关个股有Edesa Biotech, Inc.、Fibrobiologics, Inc.、Pliant Therapeutics, Inc.，振幅分别为25.80%、16.76%、13.60%。Pmv Pharmaceuticals, Inc.公司简介：PMV Pharmaceuticals Inc是一家精密肿瘤学公司。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202502132233569621bc6d&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202502132233569621bc6d&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","PMVP"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2503493579","title":"Pmv Pharmaceuticals, Inc.盘中异动 快速上涨7.91%报1.50美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2503493579","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2503493579?lang=zh_cn&edition=full","pubTime":"2025-01-14 22:31","pubTimestamp":1736865077,"startTime":"0","endTime":"0","summary":"北京时间2025年01月14日22时31分，Pmv Pharmaceuticals, Inc.股票出现异动，股价大幅上涨7.91%。截至发稿，该股报1.50美元/股，成交量2609股，换手率0.01%，振幅0.36%。Pmv Pharmaceuticals, Inc.股票所在的生物技术行业中，整体跌幅为0.06%。其相关个股中，Nls Pharmaceutics Ltd C/Wts 02/02/2026、Eterna Therapeutics Inc.、Seastar Medical Holding Corp C/Wts 28/10/2027 涨幅较大，Soligenix, Inc.、Phio Pharmaceuticals Corp.、Eterna Therapeutics Inc.较为活跃，换手率分别为346.67%、209.02%、109.66%，振幅较大的相关个股有Eterna Therapeutics Inc.、Psyence Biomedical Ltd C/Wts 25/01/2029、Fate Therapeutics, Inc.，振幅分别为32.98%、13.30%、11.24%。Pmv Pharmaceuticals, Inc.公司简介：PMV Pharmaceuticals Inc是一家精密肿瘤学公司。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025011422311798660260&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025011422311798660260&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","PMVP"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2502901418","title":"Pmv Pharmaceuticals, Inc.盘中异动 股价大跌5.30%报1.43美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2502901418","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2502901418?lang=zh_cn&edition=full","pubTime":"2025-01-11 01:42","pubTimestamp":1736530945,"startTime":"0","endTime":"0","summary":"北京时间2025年01月11日01时42分，Pmv Pharmaceuticals, Inc.股票出现异动，股价大幅跳水5.30%。截至发稿，该股报1.43美元/股，成交量15.4294万股，换手率0.30%，振幅4.30%。Pmv Pharmaceuticals, Inc.股票所在的生物技术行业中，整体跌幅为1.99%。其相关个股中，Conduit Pharmaceuticals Inc.、Neurosense Therapeutics Ltd C/Wts 10/11/2026 、Omniab Inc C/Wts 涨幅较大，Zyversa Therapeutics, Inc.、Conduit Pharmaceuticals Inc.、Precision Biosciences, Inc.较为活跃，换手率分别为1228.17%、829.24%、230.12%，振幅较大的相关个股有Lexaria Bioscience Corp C/Wts 14/01/2026 、Conduit Pharmaceuticals Inc.、Conduit Pharmaceuticals Inc C/Wts 22/09/2028，振幅分别为108.20%、100.85%、64.55%。Pmv Pharmaceuticals, Inc.公司简介：PMV Pharmaceuticals Inc是一家精密肿瘤学公司。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250111014225aba62d30&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250111014225aba62d30&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","PMVP"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2483306748","title":"Pmv Pharmaceuticals, Inc.2024财年第三财季实现净利润-19.23百万美元，同比减少15.56%","url":"https://stock-news.laohu8.com/highlight/detail?id=2483306748","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2483306748?lang=zh_cn&edition=full","pubTime":"2024-11-16 00:00","pubTimestamp":1731686435,"startTime":"0","endTime":"0","summary":"11月16日，Pmv Pharmaceuticals, Inc.公布财报，公告显示公司2024财年第三财季净利润为-19.23百万美元，同比减少15.56%；其中营业收入为0.00美元，每股基本收益为-0.37美元。从资产负债表来看，Pmv Pharmaceuticals, Inc.总负债25.59百万美元，其中短期债务1.24百万美元，资产负债比为0.09，流动比率为0.15。机构评级：截至2024年11月16日，当前有6家机构对Pmv Pharmaceuticals, Inc.目标价做出预测，其中目标均价为7.83美元，其中最低目标价为5.00美元，最高目标价为18.00美元。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241116000315abc51601&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":["earning"],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241116000315abc51601&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["PMVP"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2481138318","title":"Pmv Pharmaceuticals, Inc.盘中异动 早盘股价大涨5.42%","url":"https://stock-news.laohu8.com/highlight/detail?id=2481138318","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2481138318?lang=zh_cn&edition=full","pubTime":"2024-11-08 00:05","pubTimestamp":1730995506,"startTime":"0","endTime":"0","summary":"北京时间2024年11月08日00时05分，Pmv Pharmaceuticals, Inc.股票出现异动，股价急速拉升5.42%。截至发稿，该股报1.75美元/股，成交量18.0893万股，换手率0.35%，振幅5.42%。Pmv Pharmaceuticals, Inc.股票所在的生物技术行业中，整体涨幅为0.07%。其相关个股中，Celularity Inc.、Ensysce Biosciences, Inc.、Tevogen Bio Holdings Inc C/Wts 14/02/2029 涨幅较大，Ensysce Biosciences, Inc.、Elevai Labs, Inc.、Cyclacel Pharmaceuticals, Inc.较为活跃，换手率分别为809.76%、201.72%、96.63%，振幅较大的相关个股有Celularity Inc.、180 Life Sciences Corp C/Wts 07/11/2025、Ensysce Biosciences, Inc.，振幅分别为84.83%、68.89%、57.79%。Pmv Pharmaceuticals, Inc.公司简介：PMV Pharmaceuticals Inc是一家精密肿瘤学公司。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241108000506971a5248&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241108000506971a5248&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["PMVP","BK4139"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2477632545","title":"Pmv Pharmaceuticals, Inc.盘中异动 早盘股价大涨5.41%报1.69美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2477632545","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2477632545?lang=zh_cn&edition=full","pubTime":"2024-10-24 21:52","pubTimestamp":1729777966,"startTime":"0","endTime":"0","summary":"北京时间2024年10月24日21时52分，Pmv Pharmaceuticals, Inc.股票出现波动，股价快速拉升5.41%。截至发稿，该股报1.69美元/股，成交量8634股，换手率0.02%，振幅0.00%。Pmv Pharmaceuticals, Inc.股票所在的生物技术行业中，整体涨幅为0.52%。其相关个股中，Psyence Biomedical Ltd C/Wts 25/01/2029、Dbv Technologies、再鼎医药涨幅较大，Qualigen Therapeutics, Inc.、Cns Pharmaceuticals, Inc.、Genprex, Inc.较为活跃，换手率分别为215.43%、127.69%、53.56%，振幅较大的相关个股有Psyence Biomedical Ltd C/Wts 25/01/2029、Tevogen Bio Holdings Inc C/Wts 14/02/2029 、180 Life Sciences Corp C/Wts 07/11/2025，振幅分别为45.75%、40.08%、25.62%。Pmv Pharmaceuticals, Inc.公司简介：PMV Pharmaceuticals Inc是一家精密肿瘤学公司。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024102421524698e3e40b&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024102421524698e3e40b&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["PMVP","BK4139"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2477363294","title":"Pmv Pharmaceuticals, Inc.盘中异动 下午盘快速拉升5.03%","url":"https://stock-news.laohu8.com/highlight/detail?id=2477363294","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2477363294?lang=zh_cn&edition=full","pubTime":"2024-10-23 01:16","pubTimestamp":1729617376,"startTime":"0","endTime":"0","summary":"北京时间2024年10月23日01时16分，Pmv Pharmaceuticals, Inc.股票出现异动，股价快速上涨5.03%。截至发稿，该股报1.67美元/股，成交量15.4846万股，换手率0.30%，振幅4.28%。Pmv Pharmaceuticals, Inc.股票所在的生物技术行业中，整体跌幅为1.03%。其相关个股中，Ensysce Biosciences, Inc.、Genprex, Inc.、Silexion Therapeutics Corp C/Wts Exp 15/08/2029 涨幅较大，Genprex, Inc.、Ensysce Biosciences, Inc.、Tc Biopharm  Plc较为活跃，换手率分别为5360.71%、4826.78%、2092.11%，振幅较大的相关个股有Ensysce Biosciences, Inc.、Genprex, Inc.、Aptevo Therapeutics Inc.，振幅分别为189.27%、101.99%、99.41%。Pmv Pharmaceuticals, Inc.公司简介：PMV Pharmaceuticals Inc是一家精密肿瘤学公司。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024102301161698e3dd17&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024102301161698e3dd17&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["PMVP","BK4139"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2475133916","title":"Pmv Pharmaceuticals, Inc.盘中异动 早盘股价大涨5.03%","url":"https://stock-news.laohu8.com/highlight/detail?id=2475133916","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2475133916?lang=zh_cn&edition=full","pubTime":"2024-10-16 22:27","pubTimestamp":1729088877,"startTime":"0","endTime":"0","summary":"北京时间2024年10月16日22时27分，Pmv Pharmaceuticals, Inc.股票出现异动，股价大幅拉升5.03%。Pmv Pharmaceuticals, Inc.股票所在的生物技术行业中，整体跌幅为0.93%。其相关个股中，180 Life Sciences Corp.、180 Life Sciences Corp C/Wts 07/11/2025、Korro Bio, Inc.涨幅较大，180 Life Sciences Corp.、Biodexa Pharmaceuticals Plc、Quoin Pharmaceuticals Ltd较为活跃，换手率分别为5177.01%、969.89%、356.86%，振幅较大的相关个股有180 Life Sciences Corp.、180 Life Sciences Corp C/Wts 07/11/2025、Klotho Neurosciences Inc C/Wts 21/06/2029 ，振幅分别为623.68%、279.52%、121.40%。Pmv Pharmaceuticals, Inc.公司简介：PMV Pharmaceuticals Inc是一家精密肿瘤学公司。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024101622275898e3ccc4&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024101622275898e3ccc4&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","PMVP"],"isVideo":false,"video":null,"gpt_icon":0}],"profile":{"websiteUrl":"http://www.pmvpharma.com","stockEarnings":[{"period":"1week","weight":0.0345},{"period":"1month","weight":-0.0559},{"period":"3month","weight":0.2162},{"period":"6month","weight":-0.0288},{"period":"1year","weight":-0.0493},{"period":"ytd","weight":0.08}],"compareEarnings":[{"period":"1week","weight":0.0071},{"period":"1month","weight":0.0068},{"period":"3month","weight":0.0299},{"period":"6month","weight":0.0676},{"period":"1year","weight":0.1192},{"period":"ytd","weight":0.1282}],"compareStock":{"symbol":"SPY","name":"标普500ETF"},"description":"Pmv Pharmaceuticals, Inc.于2013年3月在特拉华州成立。该公司是一家精密肿瘤学公司，致力于发现和开发针对p53突变的小分子，与肿瘤无关的疗法。p53是一种定义明确的肿瘤抑制蛋白，被称为“基因组守护者”，而正常或野生型p53具有消除癌细胞的能力。","yearOnYearQuotes":[{"month":1,"riseRate":0,"avgChangeRate":-0.239177},{"month":2,"riseRate":0.5,"avgChangeRate":0.092966},{"month":3,"riseRate":0.166667,"avgChangeRate":-0.117673},{"month":4,"riseRate":0.5,"avgChangeRate":-0.037332},{"month":5,"riseRate":0.5,"avgChangeRate":-0.041088},{"month":6,"riseRate":0.666667,"avgChangeRate":0.098107},{"month":7,"riseRate":0.666667,"avgChangeRate":0.047022},{"month":8,"riseRate":0.333333,"avgChangeRate":-0.008458},{"month":9,"riseRate":0.166667,"avgChangeRate":0.002731},{"month":10,"riseRate":0.428571,"avgChangeRate":-0.14717},{"month":11,"riseRate":0.333333,"avgChangeRate":0.030594},{"month":12,"riseRate":0.5,"avgChangeRate":0.152009}],"exchange":"NASDAQ","name":"PMV Pharmaceuticals","nameEN":"PMV Pharmaceuticals"},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":false,"isLaohu8Offline":false,"tenantId":"TBCN","deviceId":"web-server-community-laohu8-v3","version":"4.52.0","shortVersion":"4.52.0","platform":"web","vendor":"web","appName":"laohu8","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"pagemeta":{"title":"PMV Pharmaceuticals(PMVP)_个股概要_股票价格_最新资讯_行情走势_历史数据","description":"美港股上老虎。老虎社区提供PMV Pharmaceuticals(PMVP)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","keywords":"PMV Pharmaceuticals,PMVP,PMV Pharmaceuticals股票,PMV Pharmaceuticals股票老虎,PMV Pharmaceuticals股票老虎国际,PMV Pharmaceuticals行情,PMV Pharmaceuticals股票行情,PMV Pharmaceuticals股价,PMV Pharmaceuticals股市,PMV Pharmaceuticals股票价格,PMV Pharmaceuticals股票交易,PMV Pharmaceuticals股票购买,PMV Pharmaceuticals股票实时行情,购买美股,购买港股,港股开户,美股开户,美股交易,港股交易,开通美港股账户,老虎国际行情","social":{"og_title":"PMV Pharmaceuticals(PMVP)_个股概要_股票价格_最新资讯_行情走势_历史数据","og_description":"美港股上老虎。老虎社区提供PMV Pharmaceuticals(PMVP)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","og_image":"https://static.tigerbbs.com/a0b84b8debbbce3b4440f7fdd5eed2e7"}}}